Table 4 Comparison of conventional and new prognostic scoring in the derivation and validation cohorts.
Score | Derivation cohort | Validation cohort | |||||
---|---|---|---|---|---|---|---|
n | 30-day mortality | In-hospital mortality | n | 30-day mortality | In-hospital mortality | ||
CURB-65 | 0 | 0 | – | – | 0 | – | – |
1 | 314 | 9 (2.9) | 17 (5.4) | 329 | 8 (2.4) | 11 (3.3) | |
2 | 357 | 28 (7.8) | 45 (12.6) | 437 | 23 (5.3) | 29 (6.6) | |
3 | 155 | 19 (12.3) | 31 (20.0) | 278 | 31 (11.2) | 38 (13.7) | |
4 | 42 | 8 (19.0) | 14 (33.3) | 96 | 18 (18.8) | 21 (21.9) | |
5 | 4 | 2 (50.0) | 2 (50.0) | 18 | 6 (33.3) | 7 (38.9) | |
PSI class | I | 1 | 0 (0.0) | 0 (0.0) | |||
II | 67 | 0 (0.0) | 0 (0.0) | ||||
III | 223 | 1 (0.4) | 2 (0.9) | ||||
IV | 419 | 26 (6.2) | 48 (11.5) | ||||
V | 162 | 39 (24.1) | 59 (36.4) | ||||
CHUBA | 0 | 312 | 3 (1.0) | 5 (1.6) | 204 | 1 (0.5) | 1 (0.5) |
1 | 258 | 12 (4.7) | 23 (8.9) | 405 | 6 (1.5) | 11 (2.7) | |
2 | 171 | 14 (8.2) | 27 (15.8) | 293 | 24 (8.2) | 30 (10.2) | |
3 | 93 | 20 (21.5) | 32 (34.4) | 164 | 30 (18.3) | 37 (22.6) | |
4 | 33 | 14 (42.4) | 18 (54.5) | 81 | 23 (28.4) | 25 (30.9) | |
5 | 5 | 3 (60.0) | 4 (80.0) | 11 | 2 (18.2) | 2 (18.2) | |
Total population | 872 | 66 (7.6) | 109 (12.5) | 1,158 | 86 (7.4) | 106 (9.2) |